Sáb. Sep 24th, 2022

Diapositivas Programa 1

VIRUS SARS COV-2

(1).- “A Novel Coronavirus from Patients with Pneumonia in China, 2019”. Na Zhu, Dingyu Zhang , Wenling Wang, Xingwang Li, Bo Yang, Jingdong Song, Xiang Zhao, Baoying Huang, Weifeng Shi, Roujian Lu, Peihua Niu, Faxian Zhan, Xuejun Ma, Dayan Wang, Wenbo Xu, Guizhen Wu, George F Gao & Wenjie Tan. A Novel Coronavirus from Patients with Pneumonia in China, 2019

(4).- “The protein expression profile of ACE2 in human tissues”. Hikmet, F. et al. Molecular Systems Biology.
VACUNAS
(8) Carta de los Dres. Peter Doshi y Juan Gérvas al director del New England Journal of Medicine titulada “Exposición sesgada de los resultados en el “Abstract” y el “Reseachr Summary” del estudio publicado de la vacuna de Pfizer (Vacuna BNT162b2 mRNA Covid-19). Acta Médica.
(9) “Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data”. Peter Doshi. Brithis Medical Journal.
(10) “COVID-19 vaccine efficacy and effectiveness—the elephant (not)in the room” Piero Olliaro, Els Torreele y Michel Vaillant. The Lancet.
(12) Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data.
(18) Pfizer. SARS-CoV-2 mRNA Vaccine (BNT162, PF-07302048). Summary of pharmacokinetic study.
(19) Extrapulmonary manifestations of COVID-19, https://pubmed.ncbi.nlm.nih.gov/32651579/
(21) “Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons”. Tom T. Shimabukuro, M.D. et all. June 17, 2021. The New England Journal of Medicine.